Drug intelligence / Profile preview

shendan tongnao diwan

Development stage
Unknown
Lead developer
Tianjin Chase Sun Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Shendan Tongnao Diwan is a modernized Traditional Chinese Medicine (TCM) dropping pill formulation developed by Beijing Red Sun Pharmaceutical for the treatment of ischemic stroke, particularly during the recovery phase. The formulation is composed of extracts from *Panax ginseng*, *Salvia miltiorrhiza* (Danshen), *Ligusticum chuanxiong*, and Borneol. It is designed to address Wind-Phlegm and Blood-Stasis Syndrome by promoting blood circulation, removing stasis, and tonifying Qi. Pharmacologically, the drug exhibits neuroprotective properties, improves cerebral microcirculation, and inhibits platelet aggregation. Clinical development has progressed to Phase III trials in China, evaluating its efficacy in improving neurological function and daily living activities in post-stroke patients.

Brand names
Shendan Tongnao Diwan
Other names
Shendan Tongnao Dropping PillsSandan Tongnao Diwan
02

Targets

CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on shendan tongnao diwan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shendan tongnao diwan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call